BidaskClub upgraded shares of NantHealth Inc (NYSE:NH) from a sell rating to a hold rating in a report issued on Friday morning.
Other research analysts also recently issued reports about the stock. Jefferies Group LLC reduced their price target on shares of NantHealth from $5.50 to $5.00 and set a buy rating on the stock in a research report on Wednesday, August 23rd. Canaccord Genuity restated a buy rating and issued a $6.00 price target (down from $8.00) on shares of NantHealth in a research report on Monday, August 21st. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. NantHealth presently has a consensus rating of Buy and an average price target of $8.55.
Shares of NantHealth (NYSE:NH) traded down 1.07% on Friday, hitting $4.63. 1,210,847 shares of the stock were exchanged. NantHealth has a one year low of $4.00 and a one year high of $14.62. The firm’s 50 day moving average price is $4.46 and its 200 day moving average price is $5.81. The firm’s market cap is $564.61 million.
NantHealth (NYSE:NH) last posted its quarterly earnings results on Thursday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.32). NantHealth had a negative return on equity of 83.97% and a negative net margin of 267.11%. The business had revenue of $26.23 million during the quarter, compared to the consensus estimate of $31.28 million. During the same quarter in the previous year, the business posted ($0.15) earnings per share. The company’s quarterly revenue was down 16.7% compared to the same quarter last year. Equities analysts anticipate that NantHealth will post ($0.70) earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “NantHealth Inc (NH) Upgraded to “Hold” by BidaskClub” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://transcriptdaily.com/2017/09/16/nanthealth-inc-nh-upgraded-to-hold-by-bidaskclub.html.
Hedge funds have recently added to or reduced their stakes in the stock. DekaBank Deutsche Girozentrale acquired a new stake in shares of NantHealth in the 2nd quarter worth about $245,000. Highbridge Capital Management LLC acquired a new stake in shares of NantHealth in the 1st quarter worth about $998,000. National Planning Corp acquired a new stake in shares of NantHealth in the 2nd quarter worth about $473,000. Bank of America Corp DE increased its holdings in shares of NantHealth by 366.4% in the 1st quarter. Bank of America Corp DE now owns 25,069 shares of the company’s stock worth $125,000 after acquiring an additional 19,694 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of NantHealth by 20.2% in the 2nd quarter. Vanguard Group Inc. now owns 423,537 shares of the company’s stock worth $1,792,000 after acquiring an additional 71,087 shares during the period.
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.